Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase

Transfusion

Volumn 51, Issue 12, 2011, Pages 2588-2595

  Ren, Fu Rong ^{a,b,c,d,e,f,g,h,i}   Wang, Jing Xing ^{a,b,c,d,e,f,g,h,i}   Huang, Yi ^{a,b,c,d,e,f,g,h,i}   Yao, Fu Zhu ^{a,b,c,d,e,f,g,h,i}   Lv, Yun Lai ^{a,b,c,d,e,f,g,h,i}   Li, Ju Lin ^{a,b,c,d,e,f,g,h,i}   Wen, Guo Xin ^{a,b,c,d,e,f,g,h,i}   Wen, Xiu Qiong ^{a,b,c,d,e,f,g,h,i}   Liu, Jiang ^{a,b,c,d,e,f,g,h,i}   Dong, Xiang Dong ^{a,b,c,d,e,f,g,h,i}   Ma, Hong Li ^{a,b,c,d,e,f,g,h,i}   Zhou, Zhong Min ^{a,b,c,d,e,f,g,h,i}   Bi, Xin Hong ^{a,b,c,d,e,f,g,h,i}   Tu, Lin ^{a,b,c,d,e,f,g,h,i}   King, Melissa ^{a,b,c,d,e,f,g,h,i}   Nelson, Kenrad ^{a,b,c,d,e,f,g,h,i}   Ness, Paul ^{a,b,c,d,e,f,g,h,i}   Shan, Hua ^{a,b,c,d,e,f,g,h,i}  

^a Beijing Red Cross Blood Center   (China)

^b INSTITUTE OF BLOOD TRANSFUSION   (China)

^c Yunnan Kunming Blood Center   (China)

^d Luoyang Blood Center   (China)

^e Guangxi Blood Center   (China)

^f Urumqi Blood Center of Xinjiang Uygur Autonomous Region   (China)

^g Mianyang Blood Center   (China)

^h WESTAT   (United States)

ⁱ DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; NUCLEIC ACID; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CHINESE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; NUCLEIC ACID ANALYSIS; SEROLOGY; VIRUS LOAD;

ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD DONORS; CHINA; DNA, VIRAL; DONOR SELECTION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; VIRAL LOAD;

EID: 83555173495     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03215.x     Document Type: Article

References (20)

1. Mahoney FJ,. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12: 351-66. (Pubitemid 29196857)
2. World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 (Revised August 2008). WHO Web site. 2010. [cited 2010 Oct 9]. Available from: URL
3. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y,. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550-7.
4. Zhang R, Wang L, Li J,. Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen. Transfus Med 2010; 20: 322-8.
5. Zhou C, Wu X, Huang WJ, Lan HY, Gu WJ, Qi ZB, Li HM,. Evaluation of diagnostic kit for HBsAg with a quantity standard panel for HBsAg of international unit. Chin J Biol 2008; 21: 615-70.
6. Yang MH, Li L, Hung YS, Hung CS, Allain JP, Lin KS, Tsai SJ,. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion 2010; 50: 65-74.
7. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ,. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007; 47: 1783-93. (Pubitemid 47438540)
8. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 2006; 44: 1666-74. (Pubitemid 44953671)
9. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA,. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005; 45: 1247-57. (Pubitemid 41647787)
10. González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM,. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2010; 50: 221-30.
11. Stolz M, Tinguely C, Graziani M, Fontana S, Gowland P, Buser A, Michel M, Canellini G, Züger M, Schumacher P, Lelie N, Niederhauser C,. Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region. Transfusion 2010; 50: 2695-706.
12. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008; 48: 2205-13.
13. Yao FL, Ren FR, Wang ZY, Gong XY, Song ML,. Improvement of the discriminative rate of the unresolved nucleic acid testing reactive samples with viruses concentrated by centrifugation. Beijing Med 2009; 31: 687-90. (in Chinese).
14. Allain JP,. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004; 86: 83-91.
15. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ,. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008; 48: 1198-206. (Pubitemid 351793490)
16. Kleinman S, Lelie N, Busch MP,. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-89.
17. Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C, Working Group for NAT Study in Thai Blood Donations. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009; 49: 1126-35.
18. Tabuchi A, Tanaka J, Katayama K, Mizui M, Matsukura H, Yugi H, Shimada T, Miyakawa Y, Yoshizawa H,. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. J Med Virol 2008; 80: 2064-8.
19. Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schüttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E,. HBsAg non reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007; 79: S32-6. (Pubitemid 47479872)
20. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K,. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47: 1197-205. (Pubitemid 46934327)